Decoy Therapeutics Inc. share price logo

Decoy Therapeutics Inc. Share Price

NASDAQ: DCOY

Small Cap

$5.90

+0.03

(+0.51%)

as on

Decoy Therapeutics Inc. Stock Performance

as on April 18, 2026 at 6:57 am IST

  • Day's Low

    Day's High

    $5.55
    $6.48
    downward going graph

    5.93%

    Downside

    9.83%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Decoy Therapeutics Inc. share price movements today

Previous Close
$5.87
Open
$5.88
Volume
128.6K
Day's Low - High
$5.55 - $6.48

Decoy Therapeutics Inc. Historical Returns

1 Month Return
-27.35 %
3 Month Return
-46.24 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Decoy Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Decoy Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.3M

EPS (TTM)

-12.96

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-338.31%

Decoy Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Decoy Therapeutics Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Decoy Therapeutics Inc. image
Decoy Therapeutics Inc.
NA$3.3MNANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$42.7B130.51%136.818.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$110.8B98.57%28.4232.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$36.8BNA129.845.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$78.9B48.43%17.9831.41%

Decoy Therapeutics Inc. Stock’s Investor Sentiment and Interest

Search interest for Decoy Therapeutics Inc. Stock has increased by 168% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:168% versus previous 30 day period

Decoy Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
-8
Operating Income
-1
-1
-1
0
0
-9
EBITDA
-1
-1
-1
0
0
-9
Interest Expense
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
Income Before Tax
0
-1
-1
0
0
-8
Income Tax Expense
-
-
-
-
-
-
Net Income
0
-1
-1
0
0
-8
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Decoy Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
1
0
3
5
1
-
-
-
-
Gross Profit
0
0
0
3
5
1
0
0
0
-8
Operating Income
-39
-34
-22
-8
-7
-12
-31
-12
-5
-12
EBITDA
-39
-34
-21
-8
-7
-12
-22
-12
-5
-12
Interest Expense
-
-
-
-
0
-
-
-
-
-
Depreciation
-
-
-
-
-
0
0
0
0
0
Income Before Tax
-39
-34
-21
-6
-7
-12
-31
-12
-5
-12
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-39
-34
-21
-6
-7
-12
-31
-12
-5
-12
Net Profit Margin
-3907.65%
-2701.74%
-2615.57%
-200.18%
-140.49%
-693.84%
0.00%
0.00%
0.00%
0.00%

Decoy Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
0
-1
-1
0
-1
-1
0
0
-8
Operating Cash Flow
-1
-1
-1
-1
0
-1
0
-1
-1
Investing Cash Flow
-
-
-
-
-
-
-
0
0
Financing Cash Flow
0
0
0
1
0
0
0
5
6
Change in Cash
-1
-1
-1
0
0
0
-1
4
5

Decoy Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-34
-21
-6
-7
-12
-31
-12
-5
-12
Operating Cash Flow
-27
-23
-11
-10
-10
-17
-12
-4
-4
Investing Cash Flow
24
14
5
0
-
-1
-
-
0
Financing Cash Flow
0
0
3
17
28
1
6
1
12
Change in Cash
-3
-9
-2
7
18
-17
-6
-3
8

Insights on Decoy Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 21.1% return, outperforming this stock by 118.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 38.8% return, outperforming this stock by 81.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, DCOY stock has moved down by -27.4%

About Decoy Therapeutics Inc.

Decoy Therapeutics Inc. focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that reduces the complexity of drug development and manufacturing. Its IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, optimize, and manufacture peptide conjugates targeting various unmet medical needs. The company focuses on building a portfolio of peptide conjugate therapeutics focusing on infectious diseases and oncology. The company was formerly known as Salarius Pharmaceuticals, Inc. and change its name to Decoy Therapeutics Inc. in January 2026. Decoy Therapeutics Inc. is based in Cambridge, Massachusetts.
OrganisationDecoy Therapeutics Inc.
HeadquartersOne Broadway, Cambridge, MA, United States, 02142
IndustryBiotechnology
CEOMr. Frederick E. Pierce II
E-voting on sharesClick here to vote

Key Management of Decoy Therapeutics Inc.

Name

Title

Mr. Mark J. Rosenblum CPA

Executive VP & CFO

Mr. Frederick E. Pierce II

CEO & Director

Dr. Barbara Hibner Ph.D.

Chief Scientific Officer & Director

Dr. Nadeem Q. Mirza M.D., M.P.H.

Senior Vice President of Clinical Development

Mr. Peter K. Marschel M.B.A., M.S.

Chief Business Officer

FAQs

What is Decoy Therapeutics Inc. share price today?

Decoy Therapeutics Inc. share price today is $5.9 as on at the close of the market. Decoy Therapeutics Inc. share today touched a day high of $6.48 and a low of $5.55.

What is the 52 week high and 52 week low for Decoy Therapeutics Inc. share?

Decoy Therapeutics Inc. share touched a 52 week high of $ on and a 52 week low of $ on . Decoy Therapeutics Inc. stock price today i.e. is closed at $5.9,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Decoy Therapeutics Inc.'s market capitalisation today?

Decoy Therapeutics Inc. market capitalisation is $0.00T as on .

How to invest in Decoy Therapeutics Inc. Stock (DCOY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Decoy Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Decoy Therapeutics Inc. Shares that will get you 0.2542 shares as per Decoy Therapeutics Inc. share price of $5.9 per share as on April 18, 2026 at 1:27 am IST.

What is the minimum amount required to buy Decoy Therapeutics Inc. Stock (DCOY) from India?

Indian investors can start investing in Decoy Therapeutics Inc. (DCOY) shares with as little as ₹92.768 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹927.68 in Decoy Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Decoy Therapeutics Inc. share’s latest price of $5.9 as on April 18, 2026 at 1:27 am IST, you will get 1.6949 shares of Decoy Therapeutics Inc.. Learn more about fractional shares .